recA1PI Purification Removing Iron-Induced Coloration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Purified recombinant alpha1-protease inhibitor (recA1PI) solutions derived from cell culture often exhibit a yellow or amber color, which is aesthetically undesirable and requires removal for clinical and patient acceptance.

Innovation Solution

The method involves incubating the recA1PI solution with a reducing agent, such as cysteine or DTT, followed by chromatography to separate the recA1PI from the colored species, effectively reducing the iron concentration and eliminating the yellow coloration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If recA1PI is purified from cell culture using conventional methods, then the protein is obtained in high purity, but the solution develops a yellow or amber color that is aesthetically undesirable

Engineering Contradiction:
Improveprotein purityVSAvoidyellow coloration
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and removes the colored species from the recA1PI solution through chromatography. The colored species are separated from the protein using size exclusion chromatography or ion exchange chromatography, allowing the protein to be obtained in high purity without the unwanted yellow or amber coloration.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the chemical parameters of the solution by adjusting pH, ionic strength, and adding reducing agents to modify the interaction between the protein and colored species. These parameter changes enable selective separation of the colored impurities from the protein during purification.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If the yellow coloration is removed from recA1PI solution, then the aesthetic quality improves, but the protein may lose activity or require additional purification steps

Engineering Contradiction:
Improveyellow colorationVSAvoidprotein activity
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent uses reducing agents such as DTT or beta-mercaptoethanol as intermediaries to selectively reduce and remove the colored species without affecting the protein structure. These reducing agents facilitate the removal of colored impurities while maintaining protein activity through controlled chemical reduction.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces harsh mechanical purification methods with chemical reduction and selective chromatography. By using reducing agents and controlled chromatographic separation, the method achieves color removal with gentler conditions that preserve protein activity and avoid denaturation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Device complexity

If conventional purification methods are used, then the process is simple, but iron concentration and colored species remain in the solution

Engineering Contradiction:
Improvepurification process complexityVSAvoidiron concentration
Core Design Contradiction:
Device complexityVSQuantity of substance

Solution Approach 1:

The patent segments the purification process into distinct functional steps: cell lysis, initial chromatography separation, reducing agent treatment, and final chromatography purification. This segmentation allows each step to target specific impurities, progressively removing iron-containing colored species while maintaining process manageability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent implements continuous purification action through multiple sequential chromatography steps and reducing agent treatment. The process continuously removes iron and colored species from the protein solution, achieving thorough purification without requiring complex or interrupted procedures.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach results in a highly purified recA1PI with significantly reduced yellow color, maintaining the protein's activity and achieving a substantial reduction in iron concentration, thereby improving the aesthetic and functional quality of the final product.

Implementation Method 1

incubating the solution comprising recA1PI with a reducing agent... effectively reducing the iron concentration and eliminating the yellow coloration

Methodology Applied
Scientific EffectReduction: Reduction

Implementation Method 2

separating the recA1PI from the colorant... passing the reducing solution through a hydrophobic interaction chromatography (HIC) resin

Methodology Applied
Scientific EffectChromatography: Chromatography

Data Source

PatentUS9957315B2Purification of cell culture derived alpha1 protease inhibitor
Publication Date: 2018.05.01 GRIFOLS
  • US9957315B2 patent drawing
  • US9957315B2 patent drawing
  • US9957315B2 patent drawing

AI summary

Described herein are methods for purifying recombinant, cell culture derived alpha1-protease inhibitor and removing a colored species that co-purifies with the recA1PI protein. Also described are methods for reducing the iron in cell culture derived alpha1-protease inhibitor.